This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frauman, A G Articles by Harrison, L C Search for Related Content PubMed PubMed Citation Articles by Frauman, A G Articles by Harrison, L C

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 March; 13(3): 1554-1564

Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein.

Burnet Clinical Research Unit, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

ABSTRACT

The overexpression of major histocompatibility complex (MHC) class I molecules in endocrine epithelial cells is an early feature of autoimmune thyroid disease and insulin-dependent diabetes mellitus, which may reflect a cellular response, e.g., to viruses or toxins. Evidence from a transgenic model in pancreatic beta cells suggests that MHC class I overexpression could play an independent role in endocrine cell destruction. We demonstrate in this study that the transgenic overexpression of an allogeneic MHC class I protein (H-2Kb) linked to the rat thyroglobulin promoter, in H-2Kk mice homozygous for the transgene, leads to thyrocyte atrophy, hypothyroidism, growth retardation, and death. Thyrocyte atrophy occurred in the absence of lymphocytic infiltration. Tolerance to allogeneic class I was revealed by the reduced ability of primed lymphocytes from transgenic mice to lyse H-2Kb target cells in vitro. This nonimmune form of thyrocyte destruction and hypothyroidism recapitulates the beta-cell destruction and diabetes that results from transgenic overexpression of MHC class I molecules in pancreatic beta cells. Thus, we conclude that overexpression of MHC class I molecules may be a general mechanism that directly impairs endocrine epithelial cell viability.

This article has been cited by other articles:

• Pichurin, P. N., Chen, C.-R., Chazenbalk, G. D., Aliesky, H., Pham, N., Rapoport, B., McLachlan, S. M. (2006). Targeted Expression of the Human Thyrotropin Receptor A-Subunit to the Mouse Thyroid: Insight into Overcoming the Lack of Response to A-Subunit Adenovirus Immunization. J. Immunol. 176: 668-676 [Abstract] [Full Text]  
• Nagaraju, K., Raben, N., Loeffler, L., Parker, T., Rochon, P. J., Lee, E., Danning, C., Wada, R., Thompson, C., Bahtiyar, G., Craft, J., Hooft van Huijsduijnen, R., Plotz, P. (2000). From the Cover: Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc. Natl. Acad. Sci. USA 97: 9209-9214 [Abstract] [Full Text]  
• Akkaraju, S., Canaan, K., Goodnow, C. C. (1997). Self-reactive B Cells Are Not Eliminated or Inactivated by Autoantigen Expressed on Thyroid Epithelial Cells. J. Exp. Med. 186: 2005-2012 [Abstract] [Full Text]